Valiant Laboratories Regulatory Response Summary
Communication Details
Valiant Laboratories responded to the National Stock Exchange of India on July 4, 2025, addressing a clarification sought by the exchange via email dated July 1, 2025. The query concerned the financial results submitted by the company for the quarter and year ended March 31, 2025.
Company's Clarification on Financial Results
The company clarified that the Independent Auditor's Report issued by Raman S. Shah & Co., Chartered Accountants (Statutory Auditors of the Company) for the quarter and year ended March 31, 2025, inadvertently missed the note relating to the balancing figure. This omission occurred despite the requirement under the format prescribed by SEBI in Chapter III (Financial Disclosures) of the Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
The Statutory Auditor provided specific clarification stating: "The Financial Results include the result for the quarter ended March 31, 2025, being the balancing figure between the audited figures in respect of the full financial year and the published audited year to date figure up to the third quarter of the current financial year."